Consejo Asesor Científico

Giorgio Trinchieri, MD

National Cancer Institute, NIH

Frederick, MD

Dr. Giorgio Trinchieri is the director of the Cancer and Inflammation Program, the head of the Cancer Immunobiology Section, and an NIH distinguished investigator at the National Cancer Institute, National Institutes of Health.

Dr. Trinchieri has advanced our understanding of the relationship between the innate and adaptive immune systems, and discovered interleukin-12 (IL-12), which helps enhance the immune system’s ability to respond to cancer. This last achievement earned him the 1996 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, and his main focus now is on interplay between innate inflammation, the body’s bacteria, and cancer. In addition to being a member of CRI’s Scientific Advisory Council, Dr. Trinchieri serves on the both the Postdoctoral Fellowship Review Committee and the CLIP Grant Review Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.